oxybutynin and ketorolac tromethamine

oxybutynin has been researched along with ketorolac tromethamine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Beiko, DT; Brock, GB; Denstedt, JD; Knudsen, BE; Nott, L; Pautler, SE; Razvi, H; Watterson, JD	1
Ali, MS; Bhunia, P; Chattopadhyay, D; Orasugh, JT; Samanta, AP	1

Trials

1 trial(s) available for oxybutynin and ketorolac tromethamine

Article	Year
Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy. Journal of endourology, 2004, Volume: 18, Issue:8 Topics: Administration, Intravesical; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Female; Humans; Ketorolac Tromethamine; Lidocaine; Lithotripsy; Male; Mandelic Acids; Middle Aged; Pain; Parasympatholytics; Stents; Ureter	2004

Article

Year

Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy.

Journal of endourology, 2004, Volume: 18, Issue:8

Topics: Administration, Intravesical; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Female; Humans; Ketorolac Tromethamine; Lidocaine; Lithotripsy; Male; Mandelic Acids; Middle Aged; Pain; Parasympatholytics; Stents; Ureter

2004

Other Studies

2 other study(ies) available for oxybutynin and ketorolac tromethamine

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Transdermal therapeutic system: Study of cellulose nanocrystals influenced methylcellulose-chitosan bionanocomposites. International journal of biological macromolecules, 2022, Oct-01, Volume: 218 Topics: Cellulose; Chitosan; Ketorolac Tromethamine; Methylcellulose; Nanoparticles; Transdermal Patch	2022

Article

Year

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013

Transdermal therapeutic system: Study of cellulose nanocrystals influenced methylcellulose-chitosan bionanocomposites.

International journal of biological macromolecules, 2022, Oct-01, Volume: 218

Topics: Cellulose; Chitosan; Ketorolac Tromethamine; Methylcellulose; Nanoparticles; Transdermal Patch

2022